XML 129 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Mar. 31, 2022
Current assets:    
Cash and cash equivalents $ 88,930 $ 105,948
Short-term investments 282,890 289,707
Research and development incentives receivable 2,589 3,055
Prepaid expenses and other current assets 4,981 5,267
Total current assets 379,390 403,977
Property, plant and equipment, net 7,910 7,933
Research and development incentives receivable, non-current 1,296 0
Restricted cash 1,636 1,636
Right-to-use asset - operating leases 4,984 5,552
Right-to-use asset - financing leases 40,879 42,094
Total assets 436,095 461,192
Current liabilities:    
Accounts payable 3,996 3,732
Accrued expenses and other current liabilities 15,939 13,392
Operating lease liabilities, current 1,002 1,070
Financing lease liabilities, current 2,600 2,562
Total current liabilities 23,537 20,756
Operating lease liabilities, non-current 4,280 4,801
Financing lease liabilities, non-current 24,206 24,406
Total liabilities 52,023 49,963
Commitments and contingencies (Note 11)
Stockholders' equity    
Common stock, $0.001 par value; 150,000,000 shares authorized as of September 30, 2022 and March 31, 2022; 49,739,407 and 47,338,660 shares issued and outstanding as of September 30, 2022 and March 31, 2022, respectively 50 47
Additional paid-in capital 777,650 723,359
Accumulated deficit (396,559) (311,204)
Accumulated other comprehensive income (loss) 2,931 (973)
Total stockholders' equity 384,072 411,229
Total liabilities and stockholders' equity $ 436,095 $ 461,192